When comparing these values to the results from the literature, it remains questionable whether the glioblastoma-derived ApoC1 synthesis overrides the levels obtained by physiologic production in the liver or postprandial hyperlipoproteinemia (Table 3). The gene discussed is APOC1; the disease is hyperlipoproteinemia.